Hypersialylation and multiple myeloma

Hypersialylation and multiple myeloma

There is growing recognition of the importance of sialylation as a critical post translational modification in cancer. In this article we review the role of increased cell surface sialylation (hypersialylation) in Multiple Myeloma as it relates to cellular trafficking and immune evasion. Knowledge o...

Full description

Bibliographic Details
Main Authors:	Michael O’Dwyer, Siobhan Glavey, Roisin McAvera, Alessandro Natoni, Aideen E. Ryan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Hematology
Subjects:	multiple myeloma glycosylation sialic acid selectin Siglec immune evasion
Online Access:	https://www.frontiersin.org/articles/10.3389/frhem.2024.1360149/full

Similar Items

Expression of a Siglec-Fc Protein and Its Characterization
by: Kaijun Chi, et al.
Published: (2023-04-01)

Siglecs as Therapeutic Targets in Cancer
by: Jackwee Lim, et al.
Published: (2021-11-01)

Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant?
by: Chirag Dhar
Published: (2023-04-01)

Current Status on Therapeutic Molecules Targeting Siglec Receptors
by: María Pia Lenza, et al.
Published: (2020-12-01)

1438 Stromal hypersialylation within colorectal tumors contributes to immunosuppression of T cell adaptive immunity in the tumor microenvironment
by: Oliver Treacy, et al.
Published: (2023-11-01)

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases
by: Jannis Wißfeld, et al.
Published: (2024-03-01)

Sialic Acid Mimetic Microglial Sialic Acid-Binding Immunoglobulin-like Lectin Agonism: Potential to Restore Retinal Homeostasis and Regain Visual Function in Age-Related Macular Degeneration
by: Michael J. Tolentino, et al.
Published: (2023-12-01)

Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma
by: Dawn Swan, et al.
Published: (2020-04-01)

TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors
by: Roisin M. McAvera, et al.
Published: (2024-04-01)

Targeting cancer-associated glycans as a therapeutic strategy in leukemia
by: Ashraf Abdullah Saad
Published: (2022-12-01)

Siglecs-mediated immune regulation in neurological disorders
by: Huifang Tu, et al.
Published: (2024-12-01)

Bacterial sialoglycosidases in Virulence and Pathogenesis
by: Preethi Sudhakara, et al.
Published: (2019-03-01)

Lipoprotein sialylation in atherosclerosis: Lessons from mice
by: Liming Yu, et al.
Published: (2022-09-01)

Different evasion strategies in multiple myeloma
by: Chaofan Wang, et al.
Published: (2024-02-01)

Sialic Acids and Their Influence on Human NK Cell Function
by: Philip Rosenstock, et al.
Published: (2021-01-01)

Characterization of Sialic Acid-Binding Immunoglobulin-Type Lectins in Fish Reveals Teleost-Specific Structures and Expression Patterns
by: Kim F. Bornhöfft, et al.
Published: (2020-03-01)

Development of Quantifiable Assays for Detection of Hypersialylation in Oral Cancer Diagnosis
by: Shrutam Somkuwar, et al.
Published: (2024-06-01)

Adipose microenvironment promotes hypersialylation of ovarian cancer cells
by: Alexandra Fox, et al.
Published: (2024-07-01)

Myeloma /
by: 455001 Tanner, Jerome E., et al.
Published: (2008)

Successful venetoclax salvage in the setting of refractory, dialysis-dependent multiple myeloma with t(11;14)
by: Dawn Swan, et al.
Published: (2020-03-01)

Surface glycans contribute to differences between seminal prostasomes from normozoospermic and oligozoospermic men
by: Bojana Milutinović, et al.
Published: (2019-04-01)

Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes
by: Marta Lustig, et al.
Published: (2024-11-01)

Galactose up-regulates the level of Siglec-9 glycan ligand in endothelial cells to inhibit macrophage activity
by: WU Niting, et al.
Published: (2024-07-01)

Sequence variety in the CC’ loop of Siglec-8/9/3 determines the recognitions to sulfated oligosaccharides
by: Yucheng Wang, et al.
Published: (2023-01-01)

Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes
by: Mohammed Saqif Ahmad, et al.
Published: (2023-10-01)

Early in vitro results indicate that de-O-acetylated sialic acids increase Selectin binding in cancers
by: Kakali Das, et al.
Published: (2024-12-01)

Siglecs in Brain Function and Neurological Disorders
by: Shoib Sarwar Siddiqui, et al.
Published: (2019-09-01)

Comparison of glycosyl donors: a supramer approach
by: Anna V. Orlova, et al.
Published: (2024-01-01)

Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes
by: Patrizia Leone, et al.
Published: (2024-04-01)

Sialic acids: An Avenue to Target Cancer Progression, Metastasis, and Resistance to Therapy
by: Goni Mallikarjun, et al.
Published: (2022-04-01)

Glycosylation and Its Role in Immune Checkpoint Proteins: From Molecular Mechanisms to Clinical Implications
by: Jingyi Liu, et al.
Published: (2024-06-01)

The Role of Toll-like Receptors in Colorectal Cancer Progression: Evidence for Epithelial to Leucocytic Transition (ELT)
by: Kimberly A Luddy, et al.
Published: (2014-10-01)

Anaplastic morphology in IgD multiple myeloma
by: Verónica Roldán Galiacho, et al.
Published: (2023-10-01)

PSGL-1 decorated with sialyl Lewisa/x promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagement
by: Michael O’Dwyer, et al.
Published: (2024-01-01)

Oral manifestations of multiple myeloma – A systematic review
by: Padmajaa Krishnan, et al.
Published: (2024-06-01)

MANDİBULADA MULTİPL MYELOMA İKİ OLGU SUNUMU
by: Hümeyra Kocaelli
Published: (2005-05-01)

Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01)

A Report of a Symptomatic Progressive Myeloma during Pregnancy and Postpartum Period from Asymptomatic State
by: Gehad Elgabry, et al.
Published: (2023-05-01)

Molecular size and charge as dimensions to identify and characterize circulating glycoforms of human FSH, LH and TSH
by: Leif Wide, et al.
Published: (2017-10-01)

Whole-body low-dose computed tomography in primary patients with multiple myeloma
by: A. M. Danilina, et al.
Published: (2023-05-01)